Magellan Health
(MGLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 24,939 | 18,388 | 7,142 | N/A |
| Depreciation Amortization | N/A | 52,242 | 35,171 | 19,286 | N/A |
| Accounts receivable | N/A | -23,816 | -10,900 | -25,525 | N/A |
| Accounts payable and accrued liabilities | N/A | -58,747 | -60,371 | -30,664 | N/A |
| Other Working Capital | N/A | -13,428 | -789 | -14,117 | N/A |
| Other Operating Activity | 0 | 95,946 | 62,362 | 66,198 | 0 |
| Operating Cash Flow | $N/A | $77,136 | $43,861 | $22,320 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 85,466 | 91,850 | 3,739 | N/A |
| Net Acquisitions | N/A | -84,000 | -60,000 | N/A | N/A |
| Investing Cash Flow | $N/A | $1,466 | $31,850 | $3,739 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,503 | N/A | N/A |
| Debt Issued | N/A | 353,791 | 82,946 | N/A | N/A |
| Debt Repayment | N/A | -457,372 | -176,586 | -45,572 | N/A |
| Common Stock Issued | N/A | 6,572 | N/A | N/A | N/A |
| Financing Cash Flow | $N/A | $-97,009 | $-92,137 | $-45,572 | $N/A |
| Beginning Cash Position | N/A | 47,507 | 47,507 | 47,507 | N/A |
| End Cash Position | N/A | 29,100 | 31,081 | 27,994 | N/A |
| Net Cash Flow | $N/A | $-18,407 | $-16,426 | $-19,513 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 77,136 | 43,861 | 22,320 | N/A |
| Capital Expenditure | N/A | -17,962 | -11,116 | -3,169 | N/A |
| Free Cash Flow | 0 | 59,174 | 32,745 | 19,151 | 0 |